Safety and Pharmacokinetics of Abacavir (1592U89) following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

Abacavir (1592U89) is a nucleoside analog reverse transcriptase inhibitor that has been demonstrated to have selective activity against human immunodeficiency virus (HIV) in vitro and favorable safety profiles in mice and monkeys. A phase I study was conducted to evaluate the safety and pharmacokine...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Kumar, Princy N., Sweet, Donna E., McDowell, James A., Symonds, William, Lou, Yu, Hetherington, Seth, LaFon, Stephen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1999
Aiheet:	Pharmacology
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10049274/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.3.603
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!